Boston Scientific (BSX) is a publicly traded Healthcare sector company. As of September 11, 2026, BSX trades at $43.37 with a market cap of $65.16B and a P/E ratio of 17.34. BSX moved +0.63% today. Year to date, BSX is -54.49%; over the trailing twelve months it is -59.04%. Its 52-week range spans $42.20 to $109.50. Analyst consensus is strong buy with an average price target of $61.00. Rallies surfaces BSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Boston Scientific (BSX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BSX moved +0.63% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $43.37 |
| Market Cap | $65.16B |
| P/E Ratio | 17.34 |
| EPS | $2.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $109.50 |
| 52-Week Low | $42.20 |
| Volume | 8.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $21.00B |
| Net Income | $3.67B |
| Gross Margin | 69.93% |
22 analysts cover BSX: 0 strong buy, 20 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $61.00.